Evidence map›Paper›PMID 35662265›Full record

ArticleScientific reports2022

Sustainable multifunctional phenolic lipids as potential therapeutics in Dentistry.

Naile Dame-Teixeira, Reem El-Gendy, Isabela Monici Silva, Cleonice Andrade Holanda, Andressa Souza de Oliveira, Luiz Antonio Soares Romeiro, Thuy Do

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
4.0field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 3 countries.

Naile Dame-TeixeiraDepartment of Dentistry, School of Health Sciences, University of Brasilia, Campus Universitário Darcy Ribeiro - UnB, Federal District, Asa Norte, Brasilia, DF, 70910-900, Brazil. nailedame@unb.br.
Reem El-GendyDivision of Oral Biology, School of Dentistry, University of Leeds, Leeds, LS9 7TF, UK.
Isabela Monici SilvaDepartment of Dentistry, School of Health Sciences, University of Brasilia, Campus Universitário Darcy Ribeiro - UnB, Federal District, Asa Norte, Brasilia, DF, 70910-900, Brazil.
Cleonice Andrade HolandaNucleus of Tropical Medicine, School of Medicine, University of Brasilia, Federal District, Brasilia, 70910-900, Brazil.
Andressa Souza de OliveiraDepartment of Pharmacy, School of Health Sciences, University of Brasilia, Federal District, Brasilia, 70910-900, Brazil.
Luiz Antonio Soares RomeiroDepartment of Pharmacy, School of Health Sciences, University of Brasilia, Federal District, Brasilia, 70910-900, Brazil.
Thuy DoDivision of Oral Biology, School of Dentistry, University of Leeds, Leeds, LS9 7TF, UK.
Universidade de Brasília · BRUniversity of Leeds · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Phenolic lipids components of the cashew nutshell liquid (CNSL) have molecular structures capable of chemical signalling that regulate gene expression, metabolism and inflammation. This study sets out to assess how CNSL derivatives impact oral bacteria, from an antibacterial and anti-collagenolytic perspective, as well as its biocompatibility with dental pulp stem cells. Two hemi-synthetic saturated CNSL derivative compounds were selected (LDT11-Anacardic Acids-derivative and LDT409-cardanol-derivative). Bacteriostatic activity was tested against Streptococcus mutans and Veillonella parvula. Antimicrobial capacity against preformed S. mutans biofilms was investigated using a collagen-coated Calgary Biofilm Device and confocal microscopy. Clostridium histolyticum, P. gingivalis and S. mutans biofilms were used to assess anti-collagenolytic activity. Biocompatibility with human dental pulp stromal cells (HDPSCs) was investigated (MTT for viability proportion, LDH assays for cell death rate). LDTs inhibited the bacterial growth, as well as partially inhibited bacterial collagenases in concentrations higher than 5 μg/mL. Dose-response rates of biofilm cell death was observed (LDT11 at 20, 50, 100 μg/mL = 1.0 ± 0.4, 0.7 ± 0.3, 0.6 ± 0.03, respectively). Maximum cytotoxicity was 30%. After 1 week, LDT409 had no HDPSCs death. HDPSCs viability was decreased after 24 h of treatment with LDT11 and LDT409, but recovered at 72 h and showed a massive increase in viability and proliferation after 1 week. LDTs treatment was associated with odontoblast-like morphology. In conclusion, LDT11 multifunctionality and biocompatibility, stimulating dental pulp stem cells proliferation and differentiation, indicates a potential as a bio-based dental material for regenerative Dentistry. Its potential as a bacterial collagenases inhibitor to reduce collagen degradation in root/dentinal caries can be further explored.

Indexed as

AnacardiumDental CariesAnti-Bacterial AgentsBiofilmsDentistryHumansLipidsStreptococcus mutansAnti-Bacterial AgentsLipids

Identifiers

PMID35662265
PMCPMC9166758
OpenAlexW4281839652

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.